Treeline Biosciences
Biotechnology company developing precision medicines for cancer and other serious conditions using AI-driven drug discovery. Raised $621.8 million in Series A funding in September 2025, one of the largest Series A rounds in biotech history.
Location
Cambridge, Massachusetts, USA
Founded
2022
Investors
2
Categories
therapeutics, biotech, precision-medicine, oncology, ai-drug-discovery
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Casdin Capital | New York, USA | biotech-focused | series-cgrowth | 3 |
| Deerfield Management | New York, USA | biotech-focused | seedseries-a+3 | 3 |